Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA(IMP) 54440 |
|---|---|
| 2: Name of authorisation holder | CENTRE FOR PROCESS INNOVATION LIMITED |
| 3: Address(es) of manufacturing site(s) |
RNA CENTRE OF EXCELLENCE, 3 JOHN WILLIAMS BOULEVARD SOUTH, DARLINGTON, DL1 1FN, UNITED KINGDOM |
| 4: Legally registered address of authorisation holder | CENTRE FOR PROCESS INNOVATION LIMITED, 1 UNION SQUARE, CENTRAL PARK, DARLINGTON, DL1 1GL, UNITED KINGDOM |
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
| 8: Authorisation Date | 18/04/2024 |
| 9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:
RNA CENTRE OF EXCELLENCE, 3 JOHN WILLIAMS BOULEVARD SOUTH, DARLINGTON, DL1 1FN, UNITED KINGDOM
Human Investigational Medicinal Products
| Authorised Operations |
| MANUFACTURING OPERATIONS (according to part 1) |
| Part 1 - MANUFACTURING OPERATIONS |
| [ 1.3 ] Biological investigational medicinal products |
| [ 1.3.1 ] Biological medicinal products |
| [ 1.3.1.2 ] Immunological products |
| [ 1.3.1.8 ] Other biological medicinal products Low bioburden RNA and RNA-LNP bulk drug substance |
| [ 1.6 ] Quality control testing |
| [ 1.6.3 ] Chemical/Physical |
| [ 1.6.4 ] Biological |